In an effort to find novel biomarkers for ovarian cancer using gene expression profiling, we and others [11–15] have identified claudin 4 as a gene that is highly overexpressed in ovarian cancer, and thus may contribute to tumor formation and metastasis. This evidence concerns the gene CLDN4 and neoplasm.